DALLAS--(BUSINESS WIRE)--The Colossal Foundation, the 501(c)(3) charitable organization of Colossal Biosciences, the de-extinction company, today announced the launch of its Species Reintroduction ...
Colossal Biosciences, the biotech startup known for its ambitious efforts to revive extinct species like the woolly mammoth and Tasmanian tiger, is turning its attention to a more immediate crisis - ...
Add Yahoo as a preferred source to see more of our stories on Google. DALLAS – The scientists at Colossal Laboratories & Biosciences, the company that brought us modern-day dire wolves, do not tire of ...
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When CEO Ben Lamm steps into the spotlight, it’s usually to ...
Those cute dire wolves are forming a pack. If you remember, Colossal Biosciences, the company seeking to bring back the woolly mammoth, revealed in April 2025 it had successfully birthed a trio of ...
A little over a year after Colossal Biosciences launched its nonprofit arm with $50 million in funding, the Colossal Foundation has doubled its capital with another $50 million in fundraising. In the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new company, called ...
DALLAS – The scientists at Colossal Laboratories & Biosciences, the company that brought us modern-day dire wolves, do not tire of comparisons to the fictional bioengineering firm in "Jurassic Park," ...